“…Currently, numerous detection methods for ONOO – in vivo have been reported, and in which the luminescence probe method stands out for its high sensitivity, selectivity, minimal invasiveness, and ability to detect in real-time in situ. − While a diverse range of ONOO – detection probes are available, several challenges persist in monitoring ONOO – in the brains of epileptic patients. There are four primary challenges: (1) single-photon excitation probes are limited by tissue penetration depth; − (2) short-lived fluorescent probes are interfered from background fluorescent signals; (3) single-signal on–off typed luminescent probes are susceptible to optical bleaching, focal length changes, and laser intensity changes; , (4) ratiometric luminescent probes suffer from the spectral overlapping issue. , As a result, there has been considerable interest in two-photon luminescent probes for bioimaging, owing to their distinct advantages such as reduced background fluorescence interference, minimal tissue damage at low-energy excitation, and enhanced deep tissue imaging capabilities attributed to superior tissue penetration. ,− Additionally, the utilization of long-lived luminescent probes avoids the interference arising from the self-fluorescence of endogenous biological material and scattered light emitted by neighboring optical systems. , Furthermore, ratiometric luminescent probes employing the Förster resonance energy transfer (FRET) mechanism offer a viable solution to address the spectral overlap issue encountered between two emission peaks, thereby enhancing the sensitivity and precision of probe detection. ,− Hence, the strategic development of a two-photon excited, long-lived, and ratiometric luminescent probe emerges as a promising solution to address the aforementioned challenges, thereby enabling precise detection of physiologically active species within living organisms.…”